![Andrea Airale, Co-founder, President & CEO and Alessandro Ferraris, Co-founder CEO & CTO of BeonD - JEC Andrea Airale, Co-founder, President & CEO and Alessandro Ferraris, Co-founder CEO & CTO of BeonD - JEC](https://www.jeccomposites.com/wp-content/uploads/2022/05/INterview-May3-630x500.jpg)
Andrea Airale, Co-founder, President & CEO and Alessandro Ferraris, Co-founder CEO & CTO of BeonD - JEC
![Dr. Alessandro Bartolomucci featured in UMN Medical School press release for research paper entitled "Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21" | Medical School Dr. Alessandro Bartolomucci featured in UMN Medical School press release for research paper entitled "Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21" | Medical School](https://med.umn.edu/sites/med.umn.edu/files/09.04.19_alessandro_press_release.png)
Dr. Alessandro Bartolomucci featured in UMN Medical School press release for research paper entitled "Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21" | Medical School
![Tiffany & Co. on Twitter: "We are thrilled to share that Alessandro Bogliolo, Chief Executive Officer, has signed on to the #CEOAction—joining 400+ CEOs committed to advancing diversity and inclusion in the Tiffany & Co. on Twitter: "We are thrilled to share that Alessandro Bogliolo, Chief Executive Officer, has signed on to the #CEOAction—joining 400+ CEOs committed to advancing diversity and inclusion in the](https://pbs.twimg.com/media/DsjjzVoXQAAy1xR.jpg)